PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)

SUNY Upstate Medical University, Syracuse

Western Maryland Health System, Cumberland

Virginia Cancer Specialists, Fairfax

Peninsula Cancer Institute, Newport News

Duke University, Durham

Bon Secours Saint Francis Cancer Center, Greenville

Georgia Regents University, Augusta

Lynn Cancer Institute, Boca Raton

Bond Clinic, P.A., Winter Haven

Horizon Oncology Research, Inc., Lafayette

William Beaumont Hospital, Royal Oak

St. John Hospital and Medical Center, Grosse Pointe Woods

Michigan State University, Lansing

Mercy Health Saint Mary's, Grand Rapids

Avera Research Institute, Sioux Falls

Rush University Medical Center, Chicago

UHC Oncology, Lafayette

Baylor Research Institute, Dallas

University of Texas Southwestern Medical Center, Dallas

Tyler Hematology Oncology, Tyler

M.D. Anderson Cancer Center, Houston

Colorado Blood and Cancer Institute, Denver

University of Southern California, Los Angeles

Long Beach Memorial Medical Center, Long Beach

Medical Oncology Associates, PS, Spokane

Dana-Farber Cancer Institute, Boston

Fundacion de Investigacion, San Juan